Cite
Figure S4 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type
MLA
David G. Huntsman, et al. Figure S4 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4894c93c0a74a35c5fa8f6b968a5fade&authtype=sso&custid=ns315887.
APA
David G. Huntsman, Yemin Wang, Patrick Pirrotte, Lynn Hoang, Jeffrey M. Trent, Bernard E. Weissman, C. Blake Gilks, Jessica N. McAlpine, Gregg B. Morin, Anthony Karnezis, Friedrich Kommoss, Gian Luca Negri, Shane Colborne, Christine Chow, Angela Cheng, Samuel Leung, David Farnell, Isabel N. Alcazar, Khyatiben V. Pathak, … Jennifer X. Ji. (2023). Figure S4 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type.
Chicago
David G. Huntsman, Yemin Wang, Patrick Pirrotte, Lynn Hoang, Jeffrey M. Trent, Bernard E. Weissman, C. Blake Gilks, et al. 2023. “Figure S4 from Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase–Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic Type,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4894c93c0a74a35c5fa8f6b968a5fade&authtype=sso&custid=ns315887.